Shares of Ondine Biomedical Inc. (LON:OBI - Get Free Report) traded up 0.2% during trading on Friday . The company traded as high as C$8.52 and last traded at C$8.52. 16,596 shares were traded during trading, a decline of 93% from the average session volume of 240,821 shares. The stock had previously closed at C$8.50.
Ondine Biomedical Stock Down 0.2%
The company has a market cap of C$61.12 million, a P/E ratio of -2.56 and a beta of 0.10. The stock has a 50 day moving average price of C$9.18 and a 200 day moving average price of C$9.61. The company has a debt-to-equity ratio of 25.95, a quick ratio of 8.26 and a current ratio of 1.36.
About Ondine Biomedical
(
Get Free Report)
Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.
Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.
See Also
Before you consider Ondine Biomedical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ondine Biomedical wasn't on the list.
While Ondine Biomedical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
